
"The first eQMS built exclusively for medical device manufacturers"
Founded
2013
13 years
Employees
201-500
Annual Revenue
Not Disclosed
(2026)
Products
1
Greenlight Guru is a cloud, AWS-hosted eQMS vendor founded in 2013 and headquartered in Indianapolis, Indiana. The company markets itself as the first eQMS built exclusively for the medical-device industry — "designed by medical device professionals specifically and exclusively for the medical device industry." Vendor reports 1,000+ device customers across more than 500 cities on five continents.
Product family: Greenlight Guru Quality (the eQMS SKU), Greenlight Guru Ultralight (early-stage device teams), Greenlight Guru Clinical (EDC for clinical trials, separate Microsoft Azure EU deployment), and Greenlight Guru Combination Products QMS (configuration addressing 21 CFR Part 4 drug-device combination products).
Pharma relevance is limited to drug-device combination products. For finished pharmaceuticals under 21 CFR Part 211, biologics, ATMPs, CDMOs, and API manufacturers, the vendor does not claim Part 211 conformance. A CDMO running both device and pharma drug-product programmes cannot consolidate on Greenlight Guru without maintaining a separate QMS for the Part 211 programme.
Pharma relevance is limited to drug-device combination products: auto-injectors, prefilled syringes, drug-eluting implants, inhalers, on-body delivery systems, and drug-coated stents. The vendor's Combination Products QMS configuration addresses 21 CFR Part 4, CGMP for combination products. The product is organised around the design history file and master device file. The device constituent of a combination product still has to satisfy 21 CFR Part 820 design controls regardless of how the drug constituent is regulated.
Pharma-specific customer count is not segmented by the vendor. Named customers in the pharma-adjacent / drug-delivery space: Photonicare (drug-delivery / device-pharma combination), Critical Care Diagnostics. One Capterra-verified reviewer profile lists the title "VP Operations, Pharmaceuticals," indicating at least one pharma-classified user, almost certainly a combination-product or device-pharma crossover company rather than a finished-pharmaceutical manufacturer. Greenlight Guru is not positioned for finished pharmaceuticals under 21 CFR Part 211, biologics, ATMPs, vaccines, sterile fill-finish, or CDMOs serving those use cases.
Industries Served
Privately held. Funding history, ARR estimates, and other financial health indicators are undisclosed. The vendor cites a customer count of 1,000+ as evidence of growth.
A December 2025 to January 2026 pricing reset introduced a structural "package separation" that customer reports describe as producing material price increases at renewal without new functionality (OpenRegulatory, accessed 2025-12-15).
Strategic partnerships referenced: Formlabs, Ambit BST, HTEC Group.
Browse all software products offered by Greenlight Guru.
Flagship: Greenlight Guru Quality (eQMS). Modules: document control, training, design controls/DHF, ISO 14971 risk management, CAPA, nonconformance, customer feedback/complaints, supplier management, audits, change control, Products/BOM workspace. Data model differentiator: Design Inputs/Outputs, V&V, and Risk Controls are first-class objects rather than configurable forms.
Companion products: Greenlight Guru Ultralight (early-stage device teams), Greenlight Guru Clinical (ISO 14155:2020-validated EDC, ePRO/eCOA, PMCF management, a separate product running on Microsoft Azure EU), and Greenlight Guru Combination Products QMS (configuration for 21 CFR Part 4 drug-device combination products).
AI capabilities (GA per vendor): AI-suggested traceability links across DHF objects, predictive verifiability checks, AI document context for documents, suppliers, and quality events, and AI conversion of documents into training quizzes ("Documents-to-quiz"). Specific accuracy benchmarks, LLM provider disclosure, and customer-data isolation guarantees are undisclosed.
Hosted on AWS for the QMS product. Greenlight Guru Clinical runs on Microsoft Azure EU. Strategic partnerships referenced: Formlabs, Ambit BST, HTEC Group. Tier-1 SI partnerships (Deloitte, Accenture, IBM, PwC, EY) are not publicly named as direct Greenlight Guru implementation partners. PIC/S PI-011-3 "Good Practices for Computerized Systems in Regulated GxP Environments" is referenced for V&V process alignment. Industry affiliations such as ISPE, RAPS, and AAMI are undisclosed.
Cloud Partners
Personalised onboarding and an implementation plan are led by "Gurus," medtech-experienced customer-success engineers. Implementation, a validation package (IQ/OQ/PQ), and Guru-led onboarding are bundled with the licence. Extended SOP authoring, data migration, and change-management coaching are not publicly priced. Help-desk responsiveness is consistently praised in reviews. One Capterra reviewer described the customer service they received as scripted and impersonal. The validation package is refreshed with each release. Customer events and certification programmes are undisclosed.
ISO 9001:2015 and ISO 27001:2013 certifications have been held since July 2022. SOC 2 conformance is stated by the vendor; Type I vs Type II status and the report date are undisclosed. The vendor cites a G2 Quality Winter 24 report. No Gartner Magic Quadrant for QMS/EQMS placement or Forrester Wave/IDC MarketScape placement exists for the company. The vendor publishes the customer reference Monitored Therapeutics Inc. (MTI), citing six passed audits in one year including ISO and MDSAP.
Founders and senior leadership are undisclosed. The company maintains an active blog covering 21 CFR Part 11 guidance, QMSR transition, combination-products regulatory navigation, and AI in eQMS. The company positions itself as medtech-exclusive. It does not claim Part 211 conformance for finished pharmaceuticals, and it does not address complex enterprise CDMO scenarios that require running both device and pharma quality programmes.
The company maintains an active blog with frequent publication on regulatory topics, eQMS best practices, and AI features, plus a resource centre of whitepapers and webinars. No free trial is offered. Demos are conducted via sales engagement. The vendor is listed on G2, Capterra, Software Advice, and Gartner Peer Insights. A December 2025 pricing-restructuring announcement drew market visibility to renewal cost increases, per OpenRegulatory's third-party analysis.
Headquarters
Indianapolis, Indiana, United States
Founded
2013 (13 years in business)
Company Size
201-500 employees
Type
Private
Owned by Not applicable - independent company
Annual Revenue
Not Disclosed (2026)